Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Glob Chang Biol ; 23(10): 4386-4395, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28391611

RESUMO

Climate change is predicted to shift temperature regimes in most agricultural areas with temperature changes expected to impact yields of most crops, including rice. These temperature-driven effects can be classified into point stresses, where a temperature event during a sensitive stage drives a reduction in yield, or seasonal warming losses, where raised temperature is thought to increase maintenance energy demands and thereby decrease available resources for yield formation. Simultaneous estimation of the magnitude of each temperature effect on yield has not been well documented due to the inherent difficulty in separating their effects. We simultaneously quantified the magnitude of each effect for a temperate rice production system using a large data set covering multiple locations with data collected from 1995 to 2015, combined with a unique probability-based modeling approach. Point stresses, primarily cold stress during the reproductive stages (booting and flowering), were found to have the largest impact on yield (over 3 Mg/ha estimated yield losses). Contrary to previous reports, yield losses caused by increased temperatures, both seasonal and during grain-filling, were found to be small (approximately 1-2% loss per °C). Occurrences of cool temperature events during reproductive stages were found to be persistent over the study period, and within season, the likelihood of a cool temperature event increased when flowering occurred later in the season. Short and medium grain types, typically recommended for cool regions, were found to be more tolerant of cool temperatures but more sensitive to heat compared to long grain cultivars. These results suggest that for temperate rice systems, the occurrence of periodic stress events may currently overshadow the impacts of general warming temperature on crop production.


Assuntos
Mudança Climática , Oryza/crescimento & desenvolvimento , Temperatura , Produtos Agrícolas , Estações do Ano
2.
Clin Case Rep ; 9(10): e04994, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34745617

RESUMO

Management of acute pulmonary embolism depends immensely on rapid diagnosis and early intervention. Transthoracic echocardiography has gained favorability in scenarios where diagnostic computed tomography angiography is not feasible. McConnell's sign, an echocardiographic finding of segmental right ventricular wall-motion abnormality with apical sparing, is highly specific and may guide therapeutic intervention. We present the case of a 59-year-old man who was found to have acute pulmonary embolism with obstructive shock, managed successfully with thrombolytic therapy after identification of McConnell's sign. We review current literature and develop a framework for the integration of echocardiography into the multimodal approach to management.

3.
Br J Nutr ; 103(7): 1023-8, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20064284

RESUMO

Honey is an established traditional medicine with a variety of putative nutritional and health effects, including antibacterial, antioxidant, anti-inflammatory and prebiotic. The aim of the present study was to investigate the safety of consuming manuka honey, UMF 20+, on healthy individuals by establishing whether UMF 20+caused an allergic response (as measured by IgE levels), changed major commensal and beneficial microbial groups in the gut and/or affected levels of one of the most common advanced glycation endpoints, N-(carboxymethyl)-lysine (CML). The study had a randomised, double-blind cross-over design. A total of twenty healthy individuals aged 42-64 years were recruited. We tested two different honeys- a multiflora honey and UMF 20+, both produced by Comvita New Zealand Ltd (Te Puke, New Zealand). Multiflora honey or UMF 20+(20 g) was consumed daily for 4 weeks, with a 2-week 'washout' period in between. Blood samples were collected every week for each intervention period and used to measure total IgE levels in serum and advanced glycation endproducts - a consequence of methyglyoxal accumulation. Faecal samples were collected at the beginning and end of each 4-week period. DNA was extracted from faecal samples and the levels of a number of microbial groups in the gut, both beneficial and commensal, were analysed. Neither product changed the levels of IgE or CML or altered gut microbial profiles during the trial, confirming that UMF 20+is safe for healthy individuals to consume. Despite anecdotal evidence suggesting that manuka honey is good for digestive health, we observed no beneficial effects on lower gut bacterial levels with either honey in this healthy population.


Assuntos
Antibacterianos/efeitos adversos , Trato Gastrointestinal/efeitos dos fármacos , Produtos Finais de Glicação Avançada/sangue , Mel/efeitos adversos , Hipersensibilidade/etiologia , Imunoglobulina E/sangue , Leptospermum , Adulto , Antibacterianos/farmacologia , Bactérias/classificação , Bactérias/genética , Estudos Cross-Over , DNA Bacteriano/análise , Método Duplo-Cego , Fezes/microbiologia , Feminino , Trato Gastrointestinal/microbiologia , Humanos , Lisina/análogos & derivados , Lisina/sangue , Masculino , Pessoa de Meia-Idade , Valores de Referência
4.
AACE Clin Case Rep ; 6(3): e123-e126, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32524025

RESUMO

OBJECTIVE: To report a case of diabetes mellitus (DM) associated with partial pancreatic agenesis and congenital heart disease (CHD) in a patient found to have a nonsense mutation of the GATA6 gene. METHODS: We present the imaging, laboratory, and genetic findings, and describe the clinical course of a patient with an atypical presentation of DM as well as CHD, who was found to have partial pancreatic agenesis on computed tomography (CT) imaging. Genetic testing was performed to identify monogenic DM. RESULTS: A 30-year-old nonobese female with a waxing and waning pattern of insulin-dependent DM diagnosed at the age of 20 was found to have partial pancreatic agenesis on CT scan. It was unclear whether the patient was experiencing undetected hyperglycemia prior to initial diagnosis of DM. She had no history of diabetic ketoacidosis (DKA) despite poorly-controlled diabetes and years without insulin treatment. The patient also had congenital tricuspid atresia, ventricular septal defect, and transposition of the great vessels with surgical correction in childhood. Partial pancreatic agenesis and CHD with atypical DM prompted genetic testing for monogenic DM, and a nonsense mutation of the GATA6 (c.1242C>A, p.C414*) gene was found. CONCLUSION: GATA6 mutations are associated with a broad spectrum of diabetic phenotypes, pancreatic agenesis, and a variety of CHDs. This case highlights the importance of considering monogenic diabetes in young, nonobese patients with diabetes, particularly with negative pancreatic antibodies and no history of DKA. Further, this case demonstrates the importance of testing for GATA6 mutations in any young patient with diabetes and CHD.

5.
Genet Vaccines Ther ; 7: 5, 2009 Mar 09.
Artigo em Inglês | MEDLINE | ID: mdl-19272140

RESUMO

The most common cause of death of cancer sufferers is through the occurrence of metastases. The metastatic behaviour of tumour cells is regulated by extracellular growth factors such as hepatocyte growth factor (HGF), a ligand for the c-Met receptor tyrosine kinase, and aberrant expression/activation of the c-Met receptor is closely associated with metastatic progression. Nk4 (also known as Interleukin (IL)32b) is a competitive antagonist of the HGF c-Met system and inhibits c-Met signalling and tumour metastasis. Nk4 has an additional anti-angiogenic activity independent of its HGF-antagonist function. Angiogenesis-inhibitory as well as cancer-specific apoptosis inducing effects make the Nk4 sequence an attractive candidate for gene therapy of cancer. This study investigates the inhibition of tumour metastasis by gene therapy mediated production of Nk4 by the primary tumour. Optimal delivery of anti-cancer genes is vital in order to achieve the highest therapeutic responses. Non-viral plasmid delivery methods have the advantage of safety and ease of production, providing immediate transgene expression, albeit short-lived in most tumours. Sustained presence of anti-angiogenic molecules is preferable with anti-angiogenic therapies, and the long-term expression mediated by Adeno-associated Virus (AAV) might represent a more appropriate delivery in this respect. However, the incubation time required by AAV vectors to reach appropriate gene expression levels hampers efficacy in many fast-growing murine tumour models. Here, we describe murine trials assessing the effects of Nk4 on the spontaneously metastatic Lewis Lung Carcinoma (LLC) model when delivered to primary tumour via plasmid lipofection or AAV2 vector. Intratumoural AAV-Nk4 administration produced the highest therapeutic response with significant reduction in both primary tumour growth and incidence of lung metastases. Plasmid-mediated therapy also significantly reduced metastatic growth, but with moderate reduction in primary subcutaneous tumour growth. Overall, this study demonstrates the potential for Nk4 gene therapy of metastatic tumours, when delivered by AAV or non-viral methods.

6.
Biomarkers ; 14(1): 26-37, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19283521

RESUMO

The serum amyloid A protein is one of the major reactants in the acute-phase response. Using representational difference analysis comparing RNA from normal and involuting quarters of a dairy cow mammary gland, we found an mRNA encoding the SAA3 protein (M-SAA3). The M-SAA3 mRNA was localized to restricted populations of bovine mammary epithelial cells (MECs). It was expressed at a moderate level in late pregnancy, at a low level through lactation, was induced early in milk stasis, and expressed at high levels in most MECs during mid to late involution and inflammation/mastitis. The mature M-SAA3 peptide was expressed in Escherichia coli, antibodies made, and shown to have antibacterial activity against E. coli, Streptococcus uberis and Pseudomonas aeruginosa. These results suggest that the mammary SAA3 may have a role in protection of the mammary gland during remodelling and infection and possibly in the neonate gastrointestinal tract.


Assuntos
Glândulas Mamárias Animais/metabolismo , Proteína Amiloide A Sérica/metabolismo , Animais , Sequência de Bases , Northern Blotting , Western Blotting , Bovinos , Primers do DNA , Ensaio de Imunoadsorção Enzimática , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , Proteína Amiloide A Sérica/genética , Proteína Amiloide A Sérica/imunologia
7.
Int J Food Sci Nutr ; 60(8): 717-27, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19919519

RESUMO

A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions. The panel of food products tested included fruits, vegetables, grains, herbs and spices, most of which are common in a normal European-style diet. The impact of these extracts on the growth of selected probiotic bacteria (Lactobacillus reuteri, Lactobacillus rhamnosus, Bifidobacteria lactis) and pathogenic bacteria (Escherichia coli 0157:H7 and Escherichia coli LF82) was assessed using a standard minimum inhibitory concentration method. The results showed that aqueous extractions of garlic and black peppercorns significantly enhanced the growth of one strain of probiotic bacteria (L. reuteri) whilst inhibiting both pathogenic strains of E. coli at a 1:50 dilution. Aqueous extracts of banana, apple and orange all enhanced the growth of the three probiotic strains significantly, and inhibited the pathogens to approximately 80% of the controls (not significant). Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains, respectively (also at the 1:50 dilution).


Assuntos
Bifidobacterium/crescimento & desenvolvimento , Escherichia coli/crescimento & desenvolvimento , Alimentos , Lactobacillus/crescimento & desenvolvimento , Extratos Vegetais/farmacologia , Agaricales/química , Bifidobacterium/efeitos dos fármacos , Relação Dose-Resposta a Droga , Escherichia coli/efeitos dos fármacos , Trato Gastrointestinal/microbiologia , Nível de Saúde , Humanos , Concentração de Íons de Hidrogênio , Lactobacillus/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Componentes Aéreos da Planta/química , Raízes de Plantas/química , Probióticos , Solventes , Chá/química
8.
Urology ; 73(6): 1175-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19362332

RESUMO

OBJECTIVES: To examine the outcomes of 2 commonly performed urologic office procedures as a part of a process to align these with the Joint Commission standards to ensure patient safety. We determined whether cystoscopy and transrectal ultrasound-guided prostate biopsy performed in the office setting pose minimal risk to patients. METHODS: An evaluation of urologic office procedures in the office clinic setting of an academic medical center was prospectively performed during 3 different periods to document patient and system events. The patients included those undergoing cystoscopy for workup of hematuria, history of bladder cancer, or other indicated conditions (n = 554) and patients undergoing transrectal ultrasound-guided prostate biopsy for suspicion of prostate cancer (n = 367). All consecutive patients were evaluated. RESULTS: A total of 7 patient events (0.76%) and 101 system events (10.97%) were documented. The most significant adverse patient event was 1 case of acute bacterial prostatitis due to quinolone-resistant Escherichia coli. In most cases, the system event rate reflected a delay of >15 minutes in the initiation of the procedure. No patient experienced significant bleeding, perforation, or a major cardiopulmonary event. CONCLUSIONS: The results of our study have shown that cystoscopy and transrectal ultrasound-guided prostate biopsy procedures performed in the office setting pose a minimal risk to patients. This information could be useful for hospitals and practices that are undergoing efforts to align their individual policies with current Joint Commission standards.


Assuntos
Biópsia por Agulha/métodos , Cistoscopia , Próstata/diagnóstico por imagem , Próstata/patologia , Humanos , Masculino , Visita a Consultório Médico , Estudos Prospectivos , Garantia da Qualidade dos Cuidados de Saúde , Fatores de Risco , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA